Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Transarterial Chemoembolization”

297 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 297 results

Testing effectiveness (Phase 2)UnknownNCT00960518
What this trial is testing

TACE and Adefovir Compared With Transarterial Chemoembolization (TACE) Alone for Hepatitis B Virus (HBV)-Related Unresectable Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatitis B VirusHepatocellular Carcinoma
Tongji University 216
Not applicableNot Yet RecruitingNCT07183566
What this trial is testing

CT Volume Measurement of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)CT
Assiut University 66
Large-scale testing (Phase 3)Study completedNCT04246177
What this trial is testing

Safety and Efficacy of Lenvatinib (E7080/MK-7902) With Pembrolizumab (MK-3475) in Combination With Transarterial Chemoembolization (TACE) in Participants With Incurable/Non-metastatic Hepatocellular Carcinoma (MK-7902-012/E7080-G000-318/LEAP-012)

Who this might be right for
Carcinoma, Hepatocellular
Merck Sharp & Dohme LLC 479
Large-scale testing (Phase 3)Looking for participantsNCT06485466
What this trial is testing

TACE Plus Camrelizumab and Apatinib for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaTransarterial ChemoembolizationCamrelizumab+1 more
Guohui Xu 101
Not applicableUnknownNCT05631613
What this trial is testing

Lipiodol-TACE With Idarubicin Based On a Specific Emulsion Ratio for Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 40
Large-scale testing (Phase 3)Study completedNCT01259414
What this trial is testing

Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 812
Testing effectiveness (Phase 2)UnknownNCT04652492
What this trial is testing

Tislelizumab in Combination With TACE in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Zhongda Hospital 72
Testing effectiveness (Phase 2)Active Not RecruitingNCT04728633
What this trial is testing

Transarterial Chemoembolization for the Treatment of Uveal Melanoma With Liver Metastases

Who this might be right for
Metastatic Malignant Neoplasm in the LiverMetastatic Uveal MelanomaStage IV Choroidal and Ciliary Body Melanoma AJCC V8
Thomas Jefferson University 28
Testing effectiveness (Phase 2)WithdrawnNCT03782831
What this trial is testing

TACE Plus PD-1 Antibody vs TACE Alone for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University
Large-scale testing (Phase 3)UnknownNCT03939845
What this trial is testing

A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 180
Large-scale testing (Phase 3)UnknownNCT05263219
What this trial is testing

DEB-TACE+HAIC vs. HAIC for Large HCC

Who this might be right for
Unresectable Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical University 230
Large-scale testing (Phase 3)Looking for participantsNCT03895359
What this trial is testing

Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma

Who this might be right for
Hepatocellular Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 128
Not applicableWithdrawnNCT03172559
What this trial is testing

Radiotherapy Versus no Intervention in Adult Patients With Hepatocellular Carcinoma Not Eligible for Transarterial Chemoembolization or Ablation Prior to Liver Transplant (RADBRI)

Who this might be right for
Hepatocellular Carcinoma
University Health Network, Toronto
Not applicableUnknownNCT01677468
What this trial is testing

Survival According to the Feeding Artery Obliteration by Chemoembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaTransarterial Chemoembolization
Hallym University Medical Center 250
Testing effectiveness (Phase 2)Active Not RecruitingNCT07380633
What this trial is testing

Toripalimab Plus Bevacizumab Combined Three Intra-arterial Therapies (TACE, HAIC, or TACE-HAIC) for Unresectable Hepatocellular Carcinoma: a Phase 2, Multicenter Randomised Non-comparative Trial

Who this might be right for
Hepatocellular Carcinoma (HCC)
Sun Yat-sen University 90
Testing effectiveness (Phase 2)UnknownNCT03124498
What this trial is testing

Evaluate Autologous CIK Cells in Patients With Hepatocellular Carcinoma After TACE, PEIT or RFA

Who this might be right for
Hepatocellular Carcinoma
Chuan An Biotechnology Co., Ltd. 55
Not applicableUnknownNCT03614546
What this trial is testing

Clinical Trial of Radiotherapy in Treating Primary Hepatocellular Carcinoma

Who this might be right for
Primary Hepatocellular Carcinoma
The Third Xiangya Hospital of Central South University 200
Testing effectiveness (Phase 2)UnknownNCT05361161
What this trial is testing

Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)

Who this might be right for
Gastric CancerEmbolization
Gang Wu 60
Large-scale testing (Phase 3)Looking for participantsNCT07302919
What this trial is testing

Transarterial Chemoembolization (TACE) Plus ABCB1 Inhibition Versus TACE Alone in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepato Cellular Carcinoma (HCC)
University Hospital, Basel, Switzerland 152
Not applicableUnknownNCT03110055
What this trial is testing

The Effect of Grazoprevir/Elbasvir and TACE vs. TACE Alone in Prolonging Survival of Patients With Non-resectable HCV Associated HCC.

Who this might be right for
HCV, HCC
Tel-Aviv Sourasky Medical Center 20
Load More Results